CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- 6-K Event Report of Foreign Issuer
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $161.63 ($161,630)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $160.38 ($160,381)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $168.30 ($168,298)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 9,200 shares at an average $181.45 ($1,669,339)
- 4 Planned sale Director sold 1,100 shares at $180.43 ($198,473)
- 4 Planned sale Chief Financial Officer sold 6,200 shares at an average $181.50 ($1,125,303)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 11 · 215 filings